Back

Left ventricular thrombus formation after ST-elevation myocardial infarction: a prospective observational CMR study

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Innovations in CMR for coronary artery disease Cardiac Magnetic Resonance (CMR) ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Magdalena Holzknecht

Medical University of Innsbruck, Innsbruck (Austria)

6 More presentations in this session

Presentation thumbnail
Feasibility and prognostic value of vasodilator stress perfusion CMR in elderly patients > 75 years without known CAD
Doctor T. Pezel (Paris, FR)
Abstract Slides
Presentation thumbnail
The cardioprotective effect of FFR-significant multivessel disease detected by cardiac magnetic resonance imaging in patients following ST-segment elevation myocardial infarction. Results from DANAMI3
Doctor K. Ekstroem (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Atrioventricular mechanical coupling and major adverse cardiac events in female patients following acute ST elevation myocardial infarction
Doctor S. Backhaus (Bad Nauheim, DE)
Abstract Slides
Presentation thumbnail
Association with coronary high-intensity plaque on T1-weighted magnetic resonance imaging and circulating levels of malondialdehyde-modified low-density lipoprotein
Doctor D. Hiraya (Tsukuba, JP)
Abstract Slides
Presentation thumbnail
Lymphatic insufficiency increases cardiac edema after myocardial infarction as assessed by novel magnetic resonance TRAFFn and T2 relaxation times
Mr E. Yla-Herttuala (Kuopio, FI)
Abstract

Access the full session

Session thumbnail
Innovations in CMR for coronary artery disease

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
Magnetic resonance imaging is the way to go for risk assessment
thumbnail
Congress Presentation
The exciting future of cardiac magnetic resonance
thumbnail
Congress Presentation
Cardiac magnetic resonance imaging in the work-up and management of cardiac amyloidosis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources